Search Results

You are looking at 1 - 10 of 371 items for :

  • pathologic scoring system x
  • Refine by Access: All content x
Clear All
Free access

Maria Riedmeier, Lester D R Thompson, Carlos Augusto Fernandes Molina, Boris Decarolis, Christoph Härtel, Paul-G Schlegel, Martin Fassnacht, and Verena Wiegering

such as age, further pathological factors such as Ki67 proliferation index, and potentially even genetic evaluation (genomics, transcriptomics, proteomics) may be needed to augment the AFIP scoring system. Such a stratification has already been achieved

Free access

S G Creemers, R A Feelders, N Valdes, C L Ronchi, M Volante, B M van Hemel, M Luconi, M H T Ettaieb, M Mannelli, M D Chiara, M Fassnacht, M Papotti, M N Kerstens, G Nesi, H R Haak, F J van Kemenade, and L J Hofland

), consisting of nine histopathological criteria, is the most frequently used scoring system to differentiate between benign and malignant adrenocortical tumors ( Weiss et al. 1989 , Aubert et al. 2002 ) and is also recommended in the European clinical

Free access

Noriko Kimura, Ryoichi Takayanagi, Nae Takizawa, Eiji Itagaki, Takayuki Katabami, Narihiko Kakoi, Hiromi Rakugi, Yukihiro Ikeda, Akiyo Tanabe, Takeshi Nigawara, Sadayoshi Ito, Itaru Kimura, Mitsuhide Naruse, and The Phaeochromocytoma Study Group in Japan

confluent (comedo-type) tumour necrosis ( Zelinka et al . 2011 ), have been used in previous studies ( Kimura & Sasano 1990 , Linnoila et al . 1990 , Unger et al . 1991 ). Such features have been combined in a scoring system named the Phaeochromocytoma

Open access

Sara Pusceddu, Francesco Barretta, Annalisa Trama, Laura Botta, Massimo Milione, Roberto Buzzoni, Filippo De Braud, Vincenzo Mazzaferro, Ugo Pastorino, Ettore Seregni, Luigi Mariani, Gemma Gatta, Maria Di Bartolomeo, Daniela Femia, Natalie Prinzi, Jorgelina Coppa, Francesco Panzuto, Lorenzo Antonuzzo, Emilio Bajetta, Maria Pia Brizzi, Davide Campana, Laura Catena, Harry Comber, Fiona Dwane, Nicola Fazio, Antongiulio Faggiano, Dario Giuffrida, Kris Henau, Toni Ibrahim, Riccardo Marconcini, Sara Massironi, Maja Primic Žakelj, Francesca Spada, Salvatore Tafuto, Elizabeth Van Eycken, Jan Maaten Van der Zwan, Tina Žagar, Luca Giacomelli, Rosalba Miceli, and NEPscore Working Group

derived a covariate scoring system based on the 10-year OS predicted by the final Cox model. Then, a three-level prognostic score was derived for classifying patients according to their predicted 10-year OS: (i) favorable risk group: OS ≥70%; (ii

Free access

J Cros, O Hentic, V Rebours, M Zappa, N Gille, N Theou-Anton, D Vernerey, F Maire, P Lévy, P Bedossa, V Paradis, P Hammel, P Ruszniewski, and A Couvelard

characteristics of the patients and their tumors were collected from the surgical, clinical, and pathological files. Tumors were classified according to the 2010 WHO classification and the ENETS grading system ( Rindi et al. 2006 ). TEM-based regimens were

Free access

Yu-Li Chen, Cheng-Yang Chou, Ming-Cheng Chang, Han-Wei Lin, Ching-Ting Huang, Shu-Feng Hsieh, Chi-An Chen, and Wen-Fang Cheng

used as the derivation group to select target clinical and immunological factors to generate a risk-scoring system to predict patient survival. Eighty-two cases from another hospital were used as the validation group to evaluate this risk-scoring system

Free access

Sciarra Alessandro, Gentile Vincenzo, Autran Gomez Ana Maria, Salciccia Stefano, Gentilucci Alessandro, Monti Salvatore, Toscano Vincenzo, and Di Silverio Franco

-specific mortality are available in this study. A secondary aim is to evaluate the association of CgA expression with other well-defined prognostic parameters such as pathologic stage (pT), Gleason score, and serum PSA. Materials and methods

Free access

P S H Soon, A J Gill, D E Benn, A Clarkson, B G Robinson, K L McDonald, and S B Sidhu

) can be difficult. The Weiss score, a nine-point histopathological scoring system, is presently the most widely used system for classifying adrenocortical tumors (ACTs) as benign or malignant. A total score of ≤2 is typically associated with a benign

Free access

Brian Hung-Hin Lang, Chung-Yau Lo, Wai-Fan Chan, King-Yin Lam, and Koon-Yat Wan

thyroid carcinomas) under one system. This system was developed from a multivariate analysis of 507 patients from 23 European hospitals with a median follow-up of 40 months. Under this system, a prognostic score was derived and stratified into one out of

Free access

Won-Mook Choi, Jeong-Hoon Lee, Jung-Hwan Yoon, Cheol Kwak, Young Ju Lee, Young Youn Cho, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Hyeon Hoe Kim, Hyo-Cheol Kim, Sung Yong Cho, Seung Bae Lee, Hyeon Jeong, Chung Yong Kim, and Hyo-Suk Lee

having low, intermediate, or high-risk disease using the D'Amico risk stratification system: low risk – clinical stage T1c or T2a, preoperative PSA ≤10 ng/ml, and biopsy Gleason score (GSc) ≤6; intermediate risk – clinical stage T2b or 10< preoperative